Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Calvo, Tonantzin G."" wg kryterium: Autor


Wyświetlanie 1-7 z 7
Tytuł:
Live imaging of neolymphangiogenesis identifies acute antimetastatic roles of dsRNA mimics.
Autorzy:
Olmeda D; Melanoma Laboratory, Molecular Oncology Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
Cerezo-Wallis D; Melanoma Laboratory, Molecular Oncology Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
Mucientes C; Melanoma Laboratory, Molecular Oncology Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
Calvo TG; Melanoma Laboratory, Molecular Oncology Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
Cañón E; Melanoma Laboratory, Molecular Oncology Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
Alonso-Curbelo D; Melanoma Laboratory, Molecular Oncology Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
Ibarz N; Proteomics Unit, Biotechnology Programme, ProteoRed-ISCIII, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
Muñoz J; Proteomics Unit, Biotechnology Programme, ProteoRed-ISCIII, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
Rodriguez-Peralto JL; Instituto de Investigación i+12, Hospital 12 de Octubre, Universidad Complutense Madrid Medical School, Madrid, Spain.
Ortiz-Romero P; Department of Dermatology, Hospital 12 de Octubre, Universidad Complutense Madrid Medical School, Madrid, Spain.
Ortega S; Mouse Genome Editing Core Unit, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
Soengas MS; Melanoma Laboratory, Molecular Oncology Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
Pokaż więcej
Źródło:
EMBO molecular medicine [EMBO Mol Med] 2021 Dec 07; Vol. 13 (12), pp. e12924. Date of Electronic Publication: 2021 Nov 11.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Melanoma*/drug therapy
Melanoma*/pathology
RNA, Double-Stranded*
Animals ; Humans ; Mice ; Mice, Nude ; Signal Transduction
Czasopismo naukowe
Tytuł:
p62/SQSTM1 Fuels Melanoma Progression by Opposing mRNA Decay of a Selective Set of Pro-metastatic Factors.
Autorzy:
Karras P; Melanoma Laboratory, Molecular Oncology Programme, Spanish National Cancer Research Center (CNIO), Madrid 28029, Spain.
Riveiro-Falkenbach E; Hospital Universitario 12 de Octubre, Instituto Investigación i+12, Medical School, Universidad Complutense, Madrid, Spain.
Cañón E; Melanoma Laboratory, Molecular Oncology Programme, Spanish National Cancer Research Center (CNIO), Madrid 28029, Spain.
Tejedo C; Melanoma Laboratory, Molecular Oncology Programme, Spanish National Cancer Research Center (CNIO), Madrid 28029, Spain.
Calvo TG; Melanoma Laboratory, Molecular Oncology Programme, Spanish National Cancer Research Center (CNIO), Madrid 28029, Spain.
Martínez-Herranz R; Melanoma Laboratory, Molecular Oncology Programme, Spanish National Cancer Research Center (CNIO), Madrid 28029, Spain.
Alonso-Curbelo D; Melanoma Laboratory, Molecular Oncology Programme, Spanish National Cancer Research Center (CNIO), Madrid 28029, Spain.
Cifdaloz M; Melanoma Laboratory, Molecular Oncology Programme, Spanish National Cancer Research Center (CNIO), Madrid 28029, Spain.
Perez-Guijarro E; Melanoma Laboratory, Molecular Oncology Programme, Spanish National Cancer Research Center (CNIO), Madrid 28029, Spain.
Gómez-López G; Bioinformatics Unit, CNIO, Madrid 28029, Spain.
Ximenez-Embun P; Proteomics Core Unit, CNIO, Madrid 28029, Spain.
Muñoz J; Proteomics Core Unit, CNIO, Madrid 28029, Spain.
Megias D; Confocal Microscopy Unit, CNIO, Madrid 28029, Spain.
Olmeda D; Melanoma Laboratory, Molecular Oncology Programme, Spanish National Cancer Research Center (CNIO), Madrid 28029, Spain.
Moscat J; Cancer Metabolism and Signaling Networks Program, Sanford Burnham Prebys Medical Discovery Institute, 10901 North Torrey Pines Road, La Jolla, CA 92037, USA.
Ortiz-Romero PL; Hospital Universitario 12 de Octubre, Instituto Investigación i+12, Medical School, Universidad Complutense, Madrid, Spain.
Rodríguez-Peralto JL; Hospital Universitario 12 de Octubre, Instituto Investigación i+12, Medical School, Universidad Complutense, Madrid, Spain. Electronic address: .
Soengas MS; Melanoma Laboratory, Molecular Oncology Programme, Spanish National Cancer Research Center (CNIO), Madrid 28029, Spain. Electronic address: .
Pokaż więcej
Źródło:
Cancer cell [Cancer Cell] 2019 Jan 14; Vol. 35 (1), pp. 46-63.e10. Date of Electronic Publication: 2018 Dec 20.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Melanoma/*metabolism
Membrane Proteins/*genetics
Neoplasm Proteins/*genetics
RNA, Messenger/*chemistry
RNA-Binding Proteins/*metabolism
Sequestosome-1 Protein/*metabolism
Animals ; Cell Line, Tumor ; Disease Progression ; Gene Expression Profiling/methods ; Gene Expression Regulation, Neoplastic ; Humans ; Melanoma/genetics ; Membrane Proteins/chemistry ; Mice ; Neoplasm Proteins/chemistry ; Neoplasm Transplantation ; Protein Interaction Maps ; Proteomics/methods ; RNA Stability ; Tissue Array Analysis
Czasopismo naukowe
Tytuł:
Systems analysis identifies melanoma-enriched pro-oncogenic networks controlled by the RNA binding protein CELF1.
Autorzy:
Cifdaloz M; Melanoma Laboratory, Molecular Oncology Programme, Spanish National Cancer Research Center (CNIO), 28029, Madrid, Spain.
Osterloh L; Melanoma Laboratory, Molecular Oncology Programme, Spanish National Cancer Research Center (CNIO), 28029, Madrid, Spain.
Graña O; Bioinformatics Unit, CNIO, 28029, Madrid, Spain.
Riveiro-Falkenbach E; Instituto de Investigación i+12, Hospital 12 de Octubre Medical School, Universidad Complutense, 28041, Madrid, Spain.
Ximénez-Embún P; Proteomics Core Unit, CNIO, Madrid, Spain.
Muñoz J; Proteomics Core Unit, CNIO, Madrid, Spain.
Tejedo C; Melanoma Laboratory, Molecular Oncology Programme, Spanish National Cancer Research Center (CNIO), 28029, Madrid, Spain.
Calvo TG; Melanoma Laboratory, Molecular Oncology Programme, Spanish National Cancer Research Center (CNIO), 28029, Madrid, Spain.
Karras P; Melanoma Laboratory, Molecular Oncology Programme, Spanish National Cancer Research Center (CNIO), 28029, Madrid, Spain.
Olmeda D; Melanoma Laboratory, Molecular Oncology Programme, Spanish National Cancer Research Center (CNIO), 28029, Madrid, Spain.
Miñana B; Centre de Regulació Genòmica (CRG), The Barcelona Institute of Science and Technology, Barcelona, 08003, Spain.
Gómez-López G; Bioinformatics Unit, CNIO, 28029, Madrid, Spain.
Cañon E; Melanoma Laboratory, Molecular Oncology Programme, Spanish National Cancer Research Center (CNIO), 28029, Madrid, Spain.
Eyras E; Department of Experimental and Health Sciences, Universidad Pompeu Fabra, Barcelona, 08002, Spain.; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, 08010, Spain.
Guo H; Institute of Biochemistry and Molecular Biology; Medical School, RWTH Aachen University, Aachen, 52074, Germany.
Kappes F; Institute of Biochemistry and Molecular Biology; Medical School, RWTH Aachen University, Aachen, 52074, Germany.; Department of Biological Sciences, Xi'an Jiaotong-Liverpool University, No. 111, Ren Ai Road, Dushu Lake Higher Education Town, Suzhou Industrial Park (SIP), Suzhou, 215123, China.
Ortiz-Romero PL; Instituto de Investigación i+12, Hospital 12 de Octubre Medical School, Universidad Complutense, 28041, Madrid, Spain.
Rodríguez-Peralto JL; Instituto de Investigación i+12, Hospital 12 de Octubre Medical School, Universidad Complutense, 28041, Madrid, Spain.
Megías D; Confocal Microscopy Unit, (CNIO), Madrid, 28029, Spain.
Valcárcel J; Centre de Regulació Genòmica (CRG), The Barcelona Institute of Science and Technology, Barcelona, 08003, Spain.; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, 08010, Spain.
Soengas MS; Melanoma Laboratory, Molecular Oncology Programme, Spanish National Cancer Research Center (CNIO), 28029, Madrid, Spain. .
Pokaż więcej
Źródło:
Nature communications [Nat Commun] 2017 Dec 21; Vol. 8 (1), pp. 2249. Date of Electronic Publication: 2017 Dec 21.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Oncogenes*
Systems Biology*
CELF1 Protein/*physiology
Melanoma/*genetics
3' Untranslated Regions ; Biopsy ; CELF1 Protein/genetics ; CELF1 Protein/metabolism ; Cell Line, Tumor ; Cell Proliferation ; Chromosomal Proteins, Non-Histone/metabolism ; Humans ; Immunoprecipitation ; Melanoma/pathology ; Oncogene Proteins/metabolism ; Poly-ADP-Ribose Binding Proteins/metabolism ; Prognosis ; Proteomics ; RNA, Neoplasm/genetics ; Survival Analysis ; Transcriptome
Czasopismo naukowe
Tytuł:
Whole-body imaging of lymphovascular niches identifies pre-metastatic roles of midkine.
Autorzy:
Olmeda D; Melanoma Laboratory, Molecular Oncology Programme, Spanish National Cancer Research Centre (CNIO), Madrid 28029, Spain.
Cerezo-Wallis D; Melanoma Laboratory, Molecular Oncology Programme, Spanish National Cancer Research Centre (CNIO), Madrid 28029, Spain.
Riveiro-Falkenbach E; Department of Pathology, Medical School, Universidad Complutense, Instituto i+12, Hospital Universitario 12 de Octubre, Madrid 28041, Spain.
Pennacchi PC; Melanoma Laboratory, Molecular Oncology Programme, Spanish National Cancer Research Centre (CNIO), Madrid 28029, Spain.
Contreras-Alcalde M; Melanoma Laboratory, Molecular Oncology Programme, Spanish National Cancer Research Centre (CNIO), Madrid 28029, Spain.
Ibarz N; Proteomics Unit, Biotechnology Programme, Spanish National Cancer Research Centre (CNIO), Madrid 28029, Spain.
Cifdaloz M; Melanoma Laboratory, Molecular Oncology Programme, Spanish National Cancer Research Centre (CNIO), Madrid 28029, Spain.
Catena X; Melanoma Laboratory, Molecular Oncology Programme, Spanish National Cancer Research Centre (CNIO), Madrid 28029, Spain.
Calvo TG; Melanoma Laboratory, Molecular Oncology Programme, Spanish National Cancer Research Centre (CNIO), Madrid 28029, Spain.
Cañón E; Melanoma Laboratory, Molecular Oncology Programme, Spanish National Cancer Research Centre (CNIO), Madrid 28029, Spain.
Alonso-Curbelo D; Melanoma Laboratory, Molecular Oncology Programme, Spanish National Cancer Research Centre (CNIO), Madrid 28029, Spain.
Suarez J; Melanoma Laboratory, Molecular Oncology Programme, Spanish National Cancer Research Centre (CNIO), Madrid 28029, Spain.
Osterloh L; Melanoma Laboratory, Molecular Oncology Programme, Spanish National Cancer Research Centre (CNIO), Madrid 28029, Spain.
Graña O; Bioinformatics Unit, Structural Biology and Biocomputing Programme, Spanish National Cancer Research Centre (CNIO), Madrid 28029, Spain.
Mulero F; Molecular Imaging Unit, Biotechnology Programme, Spanish National Cancer Research Centre (CNIO), Madrid 28029, Spain.
Megías D; Confocal Microscopy Unit, Biotechnology Programme, Spanish National Cancer Research Centre (CNIO), Madrid 28029, Spain.
Cañamero M; Histopathology Unit, Biotechnology Programme,Spanish National Cancer Research Centre (CNIO), Madrid 28029, Spain.
Martínez-Torrecuadrada JL; Crystallography and Protein Engineering Unit, Biotechnology Programme, Spanish National Cancer Research Centre (CNIO), Madrid 28029, Spain.
Mondal C; Department of Medicine, Division of Hematology and Oncology, The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Di Martino J; Department of Medicine, Division of Hematology and Oncology, The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Lora D; CIBERESP, Instituto i+12, Hospital Universitario 12 de Octubre, Madrid 28041, Spain.
Martinez-Corral I; Transgenic Mice Unit, Biotechnology Programme, Spanish National Cancer Research Centre (CNIO), Madrid 28029, Spain.
Bravo-Cordero JJ; Department of Medicine, Division of Hematology and Oncology, The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Muñoz J; Proteomics Unit, Biotechnology Programme, Spanish National Cancer Research Centre (CNIO), Madrid 28029, Spain.
Puig S; Melanoma Unit, Dermatology Department, Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques d'August Pi i Sunyer, 08036 Barcelona, Spain.
Ortiz-Romero P; Department of Dermatology, Medical School, Universidad Complutense, Instituto i+12, Hospital Universitario 12 de Octubre, Madrid 28041, Spain.
Rodriguez-Peralto JL; Department of Pathology, Medical School, Universidad Complutense, Instituto i+12, Hospital Universitario 12 de Octubre, Madrid 28041, Spain.
Ortega S; Transgenic Mice Unit, Biotechnology Programme, Spanish National Cancer Research Centre (CNIO), Madrid 28029, Spain.
Soengas MS; Melanoma Laboratory, Molecular Oncology Programme, Spanish National Cancer Research Centre (CNIO), Madrid 28029, Spain.
Pokaż więcej
Źródło:
Nature [Nature] 2017 Jun 28; Vol. 546 (7660), pp. 676-680.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Cytokines/*metabolism
Lymphatic Vessels/*metabolism
Neoplasm Metastasis/*diagnostic imaging
Neoplasm Metastasis/*pathology
Whole Body Imaging/*methods
Animals ; Disease Models, Animal ; Disease Progression ; Endothelial Cells/metabolism ; Female ; Genes, Reporter ; Humans ; Lymphangiogenesis ; Lymphatic Vessels/pathology ; Male ; Melanoma/diagnostic imaging ; Melanoma/metabolism ; Melanoma/pathology ; Mice ; Midkine ; Paracrine Communication ; Prognosis ; Recurrence ; Reproducibility of Results ; TOR Serine-Threonine Kinases/metabolism ; Vascular Endothelial Growth Factor Receptor-3/analysis ; Vascular Endothelial Growth Factor Receptor-3/metabolism ; Xenograft Model Antitumor Assays
Czasopismo naukowe
Tytuł:
Lineage-specific roles of the cytoplasmic polyadenylation factor CPEB4 in the regulation of melanoma drivers.
Autorzy:
Pérez-Guijarro E; Melanoma Group, Molecular Oncology Programme, Spanish National Cancer Research Centre (CNIO), Madrid 28029, Spain.
Karras P; Melanoma Group, Molecular Oncology Programme, Spanish National Cancer Research Centre (CNIO), Madrid 28029, Spain.
Cifdaloz M; Melanoma Group, Molecular Oncology Programme, Spanish National Cancer Research Centre (CNIO), Madrid 28029, Spain.
Martínez-Herranz R; Melanoma Group, Molecular Oncology Programme, Spanish National Cancer Research Centre (CNIO), Madrid 28029, Spain.
Cañón E; Melanoma Group, Molecular Oncology Programme, Spanish National Cancer Research Centre (CNIO), Madrid 28029, Spain.
Graña O; Bioinformatics Unit (CNIO), Madrid 28029, Spain.
Horcajada-Reales C; Department of Dermatology, Hospital Gregorio Marañón, Madrid 28003, Spain.
Alonso-Curbelo D; Melanoma Group, Molecular Oncology Programme, Spanish National Cancer Research Centre (CNIO), Madrid 28029, Spain.
Calvo TG; Melanoma Group, Molecular Oncology Programme, Spanish National Cancer Research Centre (CNIO), Madrid 28029, Spain.
Gómez-López G; Bioinformatics Unit (CNIO), Madrid 28029, Spain.
Bellora N; Department of Experimental and Health Sciences, Universidad Pompeu Fabra, Barcelona 08002, Spain.
Riveiro-Falkenbach E; Instituto de Investigación i+12, Hospital 12 de Octubre, Medical School, Universidad Complutense, Madrid 28041, Spain.
Ortiz-Romero PL; Instituto de Investigación i+12, Hospital 12 de Octubre, Medical School, Universidad Complutense, Madrid 28041, Spain.
Rodríguez-Peralto JL; Instituto de Investigación i+12, Hospital 12 de Octubre, Medical School, Universidad Complutense, Madrid 28041, Spain.
Maestre L; Monoclonal Antibodies Unit, Biotechnology Programme (CNIO), Madrid 28029, Spain.
Roncador G; Monoclonal Antibodies Unit, Biotechnology Programme (CNIO), Madrid 28029, Spain.
de Agustín Asensio JC; Department of Pediatric Surgery, Hospital Gregorio Marañón, Madrid 28003, Spain.
Goding CR; Institute for Cancer Research, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7DQ, Spain.
Eyras E; Department of Experimental and Health Sciences, Universidad Pompeu Fabra, Barcelona 08002, Spain.; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona 08010, Spain.
Megías D; Confocal Microscopy Unit, (CNIO) Madrid 28029, Spain.
Méndez R; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona 08010, Spain.; Translational Control of Cell Cycle and Differentiation Group, Molecular Medicine Department, Institute for Research in Biomedicine (IRB), The Barcelona Institute of Science and Technology, Barcelona 08028, Spain.
Soengas MS; Melanoma Group, Molecular Oncology Programme, Spanish National Cancer Research Centre (CNIO), Madrid 28029, Spain.
Pokaż więcej
Źródło:
Nature communications [Nat Commun] 2016 Nov 18; Vol. 7, pp. 13418. Date of Electronic Publication: 2016 Nov 18.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Melanoma/*metabolism
RNA-Binding Proteins/*metabolism
Animals ; Cell Cycle ; Cell Line, Tumor ; Gene Expression Regulation, Neoplastic ; Gene Silencing ; Humans ; Melanoma/genetics ; Mice ; Neoplasms, Experimental ; RNA, Messenger/metabolism ; RNA-Binding Proteins/genetics
Czasopismo naukowe
Tytuł:
RAB7 controls melanoma progression by exploiting a lineage-specific wiring of the endolysosomal pathway.
Autorzy:
Alonso-Curbelo D; Melanoma Laboratory, Molecular Oncology Programme, Spanish National Cancer Research Centre (CNIO), Madrid 28029, Spain.
Riveiro-Falkenbach E; Melanoma Laboratory, Molecular Oncology Programme, Spanish National Cancer Research Centre (CNIO), Madrid 28029, Spain.
Pérez-Guijarro E; Melanoma Laboratory, Molecular Oncology Programme, Spanish National Cancer Research Centre (CNIO), Madrid 28029, Spain.
Cifdaloz M; Melanoma Laboratory, Molecular Oncology Programme, Spanish National Cancer Research Centre (CNIO), Madrid 28029, Spain.
Karras P; Melanoma Laboratory, Molecular Oncology Programme, Spanish National Cancer Research Centre (CNIO), Madrid 28029, Spain.
Osterloh L; Melanoma Laboratory, Molecular Oncology Programme, Spanish National Cancer Research Centre (CNIO), Madrid 28029, Spain.
Megías D; Confocal Microscopy Unit, Biotechnology Programme, Spanish National Cancer Research Centre (CNIO), Madrid 28029, Spain.
Cañón E; Melanoma Laboratory, Molecular Oncology Programme, Spanish National Cancer Research Centre (CNIO), Madrid 28029, Spain.
Calvo TG; Melanoma Laboratory, Molecular Oncology Programme, Spanish National Cancer Research Centre (CNIO), Madrid 28029, Spain.
Olmeda D; Melanoma Laboratory, Molecular Oncology Programme, Spanish National Cancer Research Centre (CNIO), Madrid 28029, Spain.
Gómez-López G; Bioinformatics Unit, Structural Biology and Biocomputing Programme, Spanish National Cancer Research Centre (CNIO), Madrid 28029, Spain.
Graña O; Bioinformatics Unit, Structural Biology and Biocomputing Programme, Spanish National Cancer Research Centre (CNIO), Madrid 28029, Spain.
Sánchez-Arévalo Lobo VJ; Epithelial Carcinogenesis Laboratory, Molecular Pathology Programme, Spanish National Cancer Research Centre (CNIO), Madrid 28029, Spain.
Pisano DG; Bioinformatics Unit, Structural Biology and Biocomputing Programme, Spanish National Cancer Research Centre (CNIO), Madrid 28029, Spain.
Wang HW; Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Ortiz-Romero P; Instituto de Investigación i+12, Hospital 12 de Octubre, Universidad Complutense, Madrid 28041, Spain.
Tormo D; Melanoma Laboratory, Molecular Oncology Programme, Spanish National Cancer Research Centre (CNIO), Madrid 28029, Spain.
Hoek K; Department of Dermatology, University Hospital of Zurich, Zurich 8091, Switzerland.
Rodríguez-Peralto JL; Instituto de Investigación i+12, Hospital 12 de Octubre, Universidad Complutense, Madrid 28041, Spain.
Joyce JA; Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Soengas MS; Melanoma Laboratory, Molecular Oncology Programme, Spanish National Cancer Research Centre (CNIO), Madrid 28029, Spain. Electronic address: .
Pokaż więcej
Źródło:
Cancer cell [Cancer Cell] 2014 Jul 14; Vol. 26 (1), pp. 61-76. Date of Electronic Publication: 2014 Jun 26.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Cell Lineage*
Biomarkers, Tumor/*metabolism
Lysosomes/*enzymology
Melanoma/*enzymology
Skin Neoplasms/*enzymology
rab GTP-Binding Proteins/*metabolism
Animals ; Biomarkers, Tumor/genetics ; Cell Line, Tumor ; Cell Movement ; Disease Progression ; Gene Expression Regulation, Neoplastic ; Humans ; Melanoma/genetics ; Melanoma/mortality ; Melanoma/secondary ; Melanoma/therapy ; Mice ; Neoplasm Invasiveness ; Neoplasm Staging ; Protein Transport ; Proto-Oncogene Proteins c-myc/genetics ; Proto-Oncogene Proteins c-myc/metabolism ; RNA Interference ; SOXE Transcription Factors/genetics ; SOXE Transcription Factors/metabolism ; Skin Neoplasms/genetics ; Skin Neoplasms/mortality ; Skin Neoplasms/pathology ; Skin Neoplasms/therapy ; Time Factors ; Transfection ; rab GTP-Binding Proteins/genetics ; rab7 GTP-Binding Proteins
Czasopismo naukowe
Czasopismo naukowe
    Wyświetlanie 1-7 z 7

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies